资讯 | 跟我学(GSX)财报大超预期,股价大涨9%。苹果发布业绩预警

资讯摘要

美股周二收盘涨跌不一,纳指小幅攀升,道指下跌超过160点。市场正评估公共卫生事件对美国及全球经济的影响。苹果发布预警,令避险情绪提高

 

美股资讯

北京时间2月19日凌晨,美股周二收盘涨跌不一,纳指小幅攀升,道指下跌超过160点。市场正评估公共卫生事件对美国及全球经济的影响。苹果发布预警,令避险情绪提高。

截止收盘,道指收盘下跌165.89点,或0.56%,报29232.19点;纳指涨1.57点,或0.02%,报9732.74点;标普500指数跌9.87点,或0.29%,报3370.29点。

道指成分股沃尔格林(51.86, -0.53, -1.02%)联合博姿集团(WBA)收跌1.87%,陶氏(47.74, -0.89, -1.83%)化学(DOW)收跌1.85%,苹果公司(AAPL)收跌1.83%。

热门中概股涨跌不一,阿里(220.52, 0.89, 0.41%)巴巴涨0.28%,京东(42.32, 0.35, 0.83%)涨0.83%,百度(134.18, -0.39, -0.29%)跌0.29%;嘉楠科技(5.75, -1.03, -15.19%)跌15.19%,橡果国际(16.678, -2.29, -12.06%)跌11.94%,蛋壳(12.2, -1.30, -9.63%)公寓跌9.26%,爱奇艺(25.3, -1.63, -6.05%)跌6.05%,拼多多(36.44, -0.68, -1.83%)跌1.83%;万达体育涨45.48%,无忧英语(20.4, 3.54, 21.00%)涨19.34%,跟谁学(37.86, 3.36, 9.74%)涨9.74%,瑞幸(40.34, 2.32, 6.10%)咖啡涨6.1%,蔚来(3.8, 0.03, 0.80%)汽车涨0.8%。

苹果发布业绩预警后,市场正评估美国及全球制造业与金融业可能受到的影响。美国达拉斯联储主席罗伯特-卡普兰(Robert Kaplan)周二也表示,公共卫生事件造成下行风险,美联储正在评估其对美国经济增长的影响。

苹果公司(AAPL)周一表示,由于供应商的生产受到影响,预计公司将无法达到季度业绩目标。这家公司在声明中表示:“与这些产品生产相关的每个人的健康和福祉是我们最重视的东西,目前我们正在与供应商和公共卫生专家密切协商。”苹果公司表示,预计季度营收将无法达到此前设定的630亿美元至670亿美元目标。

焦点个股

苹果发布预警后,巴克莱银行将其目标价从304美元降至297美元,维持与大市同步评级。

特斯拉(858.4, 58.37, 7.30%)收盘大涨7.3%。摩根士丹利(55.52, -0.32, -0.57%)分析师Adam Jonas在报告中称,最乐观情况下,特斯拉股价将升至1200美元。

戴尔(52.77, -0.11, -0.21%)科技公司周二称,该公司将以20.8亿美元的价格将旗下网络安全部门RSA出售给一个财团。这个财团由私募股权投资公司Symphony Technology Group、安大略省教师退休基金会和荷兰养老基金公司Alpinvest Partners牵头。

沃尔玛(119.63, 1.74, 1.48%)(WMT)宣布第四财季净收益不及预期。

跟我学(GSX)发布了截至2019年12月31日第四季度及全年未经审计财务报告。

根据披露的公告,公司业绩超出预期。在2019财年,跟谁学的净收入为21.149亿元人民币,同比增长432.3%。净利润为2.266亿元人民币,同比增长1050.3%。非美国通用会计准则净利润从去年同期的2557万元人民币增至2.869亿元人民币,同比增长1020.7%。总付费人次达到274.3万,同比增长257.6%。

作为在线教育公司,跟谁学股价在疫情炒作概念中一路昂扬。根据统计,截至2月14日收盘价34.5美元,不到两个月时间较年初上涨61%,期间最高涨幅97%。

热点中概股

来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券

 

港股资讯

北京时间2月18日,美股周一(2月17日)休市,三大指数期货收市靠稳,道指期货收涨0.21%,报29457点;标普500期货收涨0.21%,报3388点;纳指期货收涨0.36%,报9666.5点。周二开盘,港股恒指低开0.69%,随后跌逾1%。

截止收盘,恒生指数(27530.2, -429.40, -1.54%)跌1.54%,报27530.20点;国企指数跌1.39%;红筹指数跌1.62%,蓝筹股几乎全线下挫。

热点板块

苹果概念股下跌。比亚迪(45.25, 0.15, 0.33%)电子(15.56, -0.74, -4.54%)跌4.54%;舜宇光学科技(127.5, -6.50, -4.85%)跌4.85%领跌蓝筹;瑞声科技(56.7, -2.15, -3.65%)跌3.65%。

内房股下跌。融创中国(43.2, -1.75, -3.89%)跌3.89%;万科企业(30.4, -1.20, -3.80%)跌3.8%;旭辉控股跌3.66%。

汇丰控股(57.75, -1.65, -2.78%)跌2.78%,报57.75港元。汇丰控股公布2019年业绩,列账基准收入560.98亿美元,同比增加4.3%;税前利润133.47亿美元,同比减少32.9%;经调整除税前利润为222.12亿美元,同比增加5%;母公司普通股股东应占利润59.69亿美元,同比减少52.66%;每股基本盈利0.3美元,2019年每股股息0.51美元。

全天涨幅最大的5支港股通

来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券

 

中国A股资讯

北京时间2月18日,三大指数开盘涨跌不一,开盘之后指数震荡走高,创指涨1%,盘面上,半导体、大飞机板块拉升。临近上午收盘,三大指数指数集体翻绿,随后创指拉升翻红。午后,三大指数小幅回升,深成指翻红,盘面上,半导体、广电系个股拉升。临近盘尾,沪指拉升翻红。总体上,个股冲高回落,市场赚钱效应有所回落。总体上,两市个股涨多跌少,涨停家数近150只,资金观望情绪一般,总体大盘氛围尚可。

截止收盘,沪指报2984.97点,涨0.05%,成交额为3749.99亿元(上一交易日成交额为3670.14亿元);深成指报11306.49点,涨0.58%,成交额为6249.48亿元(上一交易日成交额为5701.89亿元);

从盘面上看,光刻胶、集成电路、氟化工等板块居板块涨幅榜前列,草甘膦、银行、农业种植等板块居板块跌幅榜前列。

热门板块

农药板块大跌,长青股份(10.870, -1.10, -9.19%)、诺普信(7.000, -0.70, -9.09%)大跌9%,中农立华(15.000, -1.34, -8.20%)跌8%,海利尔(26.990, -2.33, -7.95%)、雅本化学(5.240, -0.39, -6.93%)等个股纷纷跟跌。

消息面上,据新华社报道,印度称当前蝗灾已基本结束。

病毒防治概念股恒强,众生药业(15.500, 0.94, 6.46%)、精华制药(6.030, 0.55, 10.04%)、辉隆股份(7.500, 0.38, 5.34%)等盘中一度涨停,白云山(37.190, 0.95, 2.62%)、昆药集团(11.090, 0.36, 3.36%)、福安药业(6.480, 0.30, 4.85%)高开。

消息面上,科技部生物中心副主任孙燕荣在会上表示,可以明确磷酸氯喹治疗新冠肺炎具有疗效。

全天涨幅最大的5支沪港通

来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com